BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35246263)

  • 1. Enhancer promoter interactome and Mendelian randomization identify network of druggable vascular genes in coronary artery disease.
    Chignon A; Mathieu S; Rufiange A; Argaud D; Voisine P; Bossé Y; Arsenault BJ; Thériault S; Mathieu P
    Hum Genomics; 2022 Mar; 16(1):8. PubMed ID: 35246263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Coronary Artery Disease-Associated Variants on Vascular Smooth Muscle Cells.
    Solomon CU; McVey DG; Andreadi C; Gong P; Turner L; Stanczyk PJ; Khemiri S; Chamberlain JC; Yang W; Webb TR; Nelson CP; Samani NJ; Ye S
    Circulation; 2022 Sep; 146(12):917-929. PubMed ID: 35735005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CETP (Cholesteryl Ester Transfer Protein) Concentration: A Genome-Wide Association Study Followed by Mendelian Randomization on Coronary Artery Disease.
    Blauw LL; Li-Gao R; Noordam R; de Mutsert R; Trompet S; Berbée JFP; Wang Y; van Klinken JB; Christen T; van Heemst D; Mook-Kanamori DO; Rosendaal FR; Jukema JW; Rensen PCN; Willems van Dijk K
    Circ Genom Precis Med; 2018 May; 11(5):e002034. PubMed ID: 29728394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
    Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
    Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. System Genetics Including Causal Inference Identify Immune Targets for Coronary Artery Disease and the Lifespan.
    Bon-Baret V; Chignon A; Boulanger MC; Li Z; Argaud D; Arsenault BJ; Thériault S; Bossé Y; Mathieu P
    Circ Genom Precis Med; 2021 Apr; 14(2):e003196. PubMed ID: 33625251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Regulation of SMC Gene Expression and Splicing Predict Causal CAD Genes.
    Aherrahrou R; Lue D; Perry RN; Aberra YT; Khan MD; Soh JY; Örd T; Singha P; Yang Q; Gilani H; Benavente ED; Wong D; Hinkle J; Ma L; Sheynkman GM; den Ruijter HM; Miller CL; Björkegren JLM; Kaikkonen MU; Civelek M
    Circ Res; 2023 Feb; 132(3):323-338. PubMed ID: 36597873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease.
    Manousaki D; Mokry LE; Ross S; Goltzman D; Richards JB
    Circ Cardiovasc Genet; 2016 Aug; 9(4):349-56. PubMed ID: 27418593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
    Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
    Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of TCF21 Downstream Target Regions Identifies a Transcriptional Network Linking Multiple Independent Coronary Artery Disease Loci.
    Sazonova O; Zhao Y; Nürnberg S; Miller C; Pjanic M; Castano VG; Kim JB; Salfati EL; Kundaje AB; Bejerano G; Assimes T; Yang X; Quertermous T
    PLoS Genet; 2015 May; 11(5):e1005202. PubMed ID: 26020271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Analysis of a Novel Genome-Wide Association Study Signal in SMAD3 That Confers Protection From Coronary Artery Disease.
    Turner AW; Martinuk A; Silva A; Lau P; Nikpay M; Eriksson P; Folkersen L; Perisic L; Hedin U; Soubeyrand S; McPherson R
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):972-83. PubMed ID: 26966274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Regulatory Mechanisms of Smooth Muscle Cells Map to Coronary Artery Disease Risk Loci.
    Liu B; Pjanic M; Wang T; Nguyen T; Gloudemans M; Rao A; Castano VG; Nurnberg S; Rader DJ; Elwyn S; Ingelsson E; Montgomery SB; Miller CL; Quertermous T
    Am J Hum Genet; 2018 Sep; 103(3):377-388. PubMed ID: 30146127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus.
    Nanda V; Wang T; Pjanic M; Liu B; Nguyen T; Matic LP; Hedin U; Koplev S; Ma L; Franzén O; Ruusalepp A; Schadt EE; Björkegren JLM; Montgomery SB; Snyder MP; Quertermous T; Leeper NJ; Miller CL
    PLoS Genet; 2018 Nov; 14(11):e1007755. PubMed ID: 30444878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell and genome-wide Mendelian randomization identifies causative genes for gout.
    Yang Y; Hu P; Zhang Q; Ma B; Chen J; Wang B; Ma J; Liu D; Hao J; Zhou X
    Arthritis Res Ther; 2024 Jun; 26(1):114. PubMed ID: 38831441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets.
    Lempiäinen H; Brænne I; Michoel T; Tragante V; Vilne B; Webb TR; Kyriakou T; Eichner J; Zeng L; Willenborg C; Franzen O; Ruusalepp A; Goel A; van der Laan SW; Biegert C; Hamby S; Talukdar HA; Foroughi Asl H; ; Pasterkamp G; Watkins H; Samani NJ; Wittenberger T; Erdmann J; Schunkert H; Asselbergs FW; Björkegren JLM
    Sci Rep; 2018 Feb; 8(1):3434. PubMed ID: 29467471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel SNPs associated with coronary artery disease and birth weight using a pleiotropic cFDR method.
    Wu X; Lin X; Li Q; Wang Z; Zhang N; Tian M; Wang X; Deng H; Tan H
    Aging (Albany NY); 2020 Dec; 13(3):3618-3644. PubMed ID: 33411684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritization of causal genes for coronary artery disease based on cumulative evidence from experimental and in silico studies.
    Shadrina AS; Shashkova TI; Torgasheva AA; Sharapov SZ; Klarić L; Pakhomov ED; Alexeev DG; Wilson JF; Tsepilov YA; Joshi PK; Aulchenko YS
    Sci Rep; 2020 Jun; 10(1):10486. PubMed ID: 32591598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.
    Li H; Li W; Li D; Yuan L; Xu Y; Su P; Wu L; Zhang Z
    Front Endocrinol (Lausanne); 2024; 15():1366290. PubMed ID: 38915894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary artery disease.
    Kain J; Owen KA; Marion MC; Langefeld CD; Grammer AC; Lipsky PE
    Cell Rep Med; 2022 Nov; 3(11):100805. PubMed ID: 36334592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Insights Into Smooth Muscle Cell Contributions to Coronary Artery Disease.
    Wong D; Turner AW; Miller CL
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1006-1017. PubMed ID: 31043074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study-Brief Report.
    Gill D; Del Greco M F; Walker AP; Srai SKS; Laffan MA; Minelli C
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1788-1792. PubMed ID: 28684612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.